209 related articles for article (PubMed ID: 21684476)
1. Fibrosis severity and mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complex in HCV-infected patients.
El Saadany SA; Ziada DH; Farrag W; Hazaa S
Arab J Gastroenterol; 2011 Jun; 12(2):68-73. PubMed ID: 21684476
[TBL] [Abstract][Full Text] [Related]
2. Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complex.
Brown KS; Keogh MJ; Tagiuri N; Grainge MJ; Presanis JS; Ryder SD; Irving WL; Ball JK; Sim RB; Hickling TP
Clin Exp Immunol; 2007 Jan; 147(1):90-8. PubMed ID: 17177967
[TBL] [Abstract][Full Text] [Related]
3. The mannan-binding lectin pathway and lung disease in cystic fibrosis--disfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier.
Olesen HV; Jensenius JC; Steffensen R; Thiel S; Schiøtz PO
Clin Immunol; 2006 Dec; 121(3):324-31. PubMed ID: 17045845
[TBL] [Abstract][Full Text] [Related]
4. Genetic influences on mannan-binding lectin (MBL) and mannan-binding lectin associated serine protease-2 (MASP-2) activity.
Sorensen GL; Petersen I; Thiel S; Fenger M; Christensen K; Kyvik KO; Sørensen TI; Holmskov U; Jensenius JC
Genet Epidemiol; 2007 Jan; 31(1):31-41. PubMed ID: 17096357
[TBL] [Abstract][Full Text] [Related]
5. Mannan-binding lectin and mannan-binding lectin-associated serine protease 2 in acute pancreatitis.
Novovic S; Andersen AM; Ersbøll AK; Jorgensen LN; Nielsen HJ; Jensenius JC; Hansen MB
Pancreas; 2011 Oct; 40(7):1097-102. PubMed ID: 21926545
[TBL] [Abstract][Full Text] [Related]
6. Mannan-binding lectin (MBL) and MBL-associated serine protease 2 (MASP-2) genotypes in colorectal cancer.
Ytting H; Christensen IJ; Steffensen R; Alsner J; Thiel S; Jensenius JC; Hansen U; Nielsen HJ
Scand J Immunol; 2011 Feb; 73(2):122-7. PubMed ID: 21198752
[TBL] [Abstract][Full Text] [Related]
7. Mannan binding lectin-associated serine protease 1 is induced by hepatitis C virus infection and activates human hepatic stellate cells.
Saeed A; Baloch K; Brown RJ; Wallis R; Chen L; Dexter L; McClure CP; Shakesheff K; Thomson BJ
Clin Exp Immunol; 2013 Nov; 174(2):265-73. PubMed ID: 23841802
[TBL] [Abstract][Full Text] [Related]
8. Mannose-binding lectin and mannose-binding lectin-associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults.
Garcia-Laorden MI; Sole-Violan J; Rodriguez de Castro F; Aspa J; Briones ML; Garcia-Saavedra A; Rajas O; Blanquer J; Caballero-Hidalgo A; Marcos-Ramos JA; Hernandez-Lopez J; Rodriguez-Gallego C
J Allergy Clin Immunol; 2008 Aug; 122(2):368-74, 374.e1-2. PubMed ID: 18582923
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of MBL-MASP complexes.
Mayilyan KR; Presanis JS; Arnold JN; Hajela K; Sim RB
Mol Immunol; 2006 Mar; 43(8):1286-92. PubMed ID: 16102832
[TBL] [Abstract][Full Text] [Related]
10. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
Shahid M; Idrees M; Nasir B; Raja AJ; Raza SM; Amin I; Rasul A; Tayyab GU
Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):788-94. PubMed ID: 24781355
[TBL] [Abstract][Full Text] [Related]
11. Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise.
Ytting H; Christensen IJ; Thiel S; Jensenius JC; Svendsen MN; Nielsen L; Lottenburger T; Nielsen HJ
Scand J Immunol; 2007 Oct; 66(4):458-64. PubMed ID: 17850591
[TBL] [Abstract][Full Text] [Related]
12. Effects of MASP2 haplotypes and MASP-2 levels in hepatitis C-infected patients.
Silva AA; Catarino SJ; Boldt ABW; Pedroso MLA; Beltrame MH; Messias-Reason IJ
Int J Immunogenet; 2018 Jun; 45(3):118-127. PubMed ID: 29675993
[TBL] [Abstract][Full Text] [Related]
13. Increased complement classical and mannan-binding lectin pathway activities in schizophrenia.
Mayilyan KR; Arnold JN; Presanis JS; Soghoyan AF; Sim RB
Neurosci Lett; 2006 Sep; 404(3):336-41. PubMed ID: 16860475
[TBL] [Abstract][Full Text] [Related]
14. Serum concentration of complement components of the lectin pathway in maintenance hemodialysis patients, and relatively higher levels of L-Ficolin and MASP-2 in Mannose-binding lectin deficiency.
Ishii M; Ohsawa I; Inoshita H; Kusaba G; Onda K; Wakabayashi M; Ohi H; Horikoshi S; Matsushita M; Tomino Y
Ther Apher Dial; 2011 Oct; 15(5):441-7. PubMed ID: 21974696
[TBL] [Abstract][Full Text] [Related]
15. Prognosis in pediatric hematologic malignancies is associated with serum concentration of mannose-binding lectin-associated serine protease-2 (MASP-2).
Zehnder A; Fisch U; Hirt A; Niggli FK; Simon A; Ozsahin H; Schlapbach LJ; Ammann RA
Pediatr Blood Cancer; 2009 Jul; 53(1):53-7. PubMed ID: 19343776
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease 2 in endemic pemphigus foliaceus.
Messias-Reason I; Bosco DG; Nisihara RM; Jakobsen LH; Petzl-Erler ML; Jensenius JC
Clin Exp Dermatol; 2008 Jul; 33(4):495-7. PubMed ID: 18498410
[TBL] [Abstract][Full Text] [Related]
17. Serum MASP-1 in complex with MBL activates endothelial cells.
Megyeri M; Jani PK; Kajdácsi E; Dobó J; Schwaner E; Major B; Rigó J; Závodszky P; Thiel S; Cervenak L; Gál P
Mol Immunol; 2014 May; 59(1):39-45. PubMed ID: 24472859
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of lectin-pathway components in healthy neonates, children and adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2).
Sallenbach S; Thiel S; Aebi C; Otth M; Bigler S; Jensenius JC; Schlapbach LJ; Ammann RA
Pediatr Allergy Immunol; 2011 Jun; 22(4):424-30. PubMed ID: 21226765
[TBL] [Abstract][Full Text] [Related]
19. MASP interactions with plasma-derived MBL.
Laursen IA; Thielens NM; Christiansen M; Houen G
Mol Immunol; 2012 Sep; 52(2):79-87. PubMed ID: 22607836
[TBL] [Abstract][Full Text] [Related]
20. A dual role for Mannan-binding lectin-associated serine protease 2 (MASP-2) in HIV infection.
Boldt AB; Beltrame MH; Catarino SJ; Meissner CG; Tizzot R; Messias-Reason IJ
Mol Immunol; 2016 Oct; 78():48-56. PubMed ID: 27588826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
